Cargando…

Germline mutations in the p53 tumour suppressor gene: scientific, clinical and ethical challenges.

Detalles Bibliográficos
Autor principal:	Birch, J. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1992
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977946/ https://www.ncbi.nlm.nih.gov/pubmed/1520579

Ejemplares similares

Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours.
por: Shi, Y. F., et al.
Publicado: (1996)

Tumourigenesis associated with the p53 tumour suppressor gene.
por: Chang, F., et al.
Publicado: (1993)

Understanding p53 tumour suppressor network
por: Panatta, Emanuele, et al.
Publicado: (2021)

Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.
por: Barton, C. M., et al.
Publicado: (1991)

Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer
Publicado: (1992)

Designing Preclinical Studies in Germline Gene Editing: Scientific and Ethical Aspects
por: Nordgren, Anders
Publicado: (2019)

Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53.
por: Birch, J. M., et al.
Publicado: (1994)

Activation and activities of the p53 tumour suppressor protein
por: Bálint, É, et al.
Publicado: (2001)

Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma.
por: Slebos, R. J., et al.
Publicado: (1996)

No germline mutations in supposed tumour suppressor genes SAFB1 and SAFB2 in familial breast cancer with linkage to 19p
por: Bergman, Annika, et al.
Publicado: (2008)

Quantitative model for inferring dynamic regulation of the tumour suppressor gene p53
por: Wang, Junbai, et al.
Publicado: (2010)

D133p53 isoform is a direct p53 target gene that modulates p53 tumour suppressor activity
por: Aoubala, M
Publicado: (2008)

Ethical Challenges of Germline Genetic Enhancement
por: Macpherson, Ignacio, et al.
Publicado: (2019)

The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.
por: Levine, A. J., et al.
Publicado: (1994)

Investigations on a clinically and functionally unusual and novel germline p53 mutation
por: Rutherford, J, et al.
Publicado: (2002)

P53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer.
por: Dahiya, R., et al.
Publicado: (1996)

Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours.
por: Sedlacek, Z., et al.
Publicado: (1998)

The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma.
por: Joypaul, B. V., et al.
Publicado: (1994)

Germline mutation in the TP53 gene in uveal melanoma
por: Hajkova, Nikola, et al.
Publicado: (2018)

Expression of the novel tumour suppressor p33(ING1) is independent of p53
por: Cheung, K-J J, et al.
Publicado: (2000)

Germline deletions in the tumour suppressor gene FOCAD are associated with polyposis and colorectal cancer development
por: Weren, Robbert DA, et al.
Publicado: (2015)

The tumour suppressor CYLD regulates the p53 DNA damage response
por: Fernández-Majada, Vanesa, et al.
Publicado: (2016)

Cancer and Tumour Suppressor p53 Encounters at the Juncture of Sex Disparity
por: Haupt, Sue, et al.
Publicado: (2021)

The Ethics of Germline Gene Editing
por: Gyngell, Christopher, et al.
Publicado: (2016)

Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides
por: Floquet, Célia, et al.
Publicado: (2011)

Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes
por: Mühlbauer, K-R, et al.
Publicado: (2003)

The 1995 Walter Hubert Lecture--molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene.
por: Harris, C. C.
Publicado: (1996)

Clinical implications of germline mutations in breast cancer: TP53
por: Schon, Katherine, et al.
Publicado: (2017)

Algorithm for prediction of tumour suppressor p53 affinity for binding sites in DNA
por: Veprintsev, Dmitry B., et al.
Publicado: (2008)

Effects of CpG Methylation on Recognition of DNA by the Tumour Suppressor p53
por: Petrovich, Miriana, et al.
Publicado: (2009)

Structure and Stability Insights into Tumour Suppressor p53 Evolutionary Related Proteins
por: Pagano, Bruno, et al.
Publicado: (2013)

Discussion of some ‘knowns’ and some ‘unknowns’ about the tumour suppressor p53
por: Lieschke, Elizabeth, et al.
Publicado: (2018)

TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
por: Grill, Sabine, et al.
Publicado: (2020)

Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver
por: Tannapfel, A, et al.
Publicado: (1999)

Sex differences in cancer risk among germline p53 mutation carriers
por: Chompret, A, et al.
Publicado: (2004)

Evidence for allosteric variants of wild-type p53, a tumour suppressor protein.
por: Cook, A., et al.
Publicado: (1990)

P53 germline mutations in childhood cancers and cancer risk for carrier individuals
por: Chompret, A, et al.
Publicado: (2000)

Characterising Mutational Spectra of Carcinogens in the Tumour Suppressor Gene TP53 Using Human TP53 Knock-in (Hupki) Mouse Embryo Fibroblasts
por: Hölzl-Armstrong, Lisa, et al.
Publicado: (2019)

Clinical Features of Breast Cancer in South Korean Patients with Germline TP53 Gene Mutations
por: Alyami, Hassan, et al.
Publicado: (2021)

Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of Germline Tumor Suppressor Mutations
por: Balabanski, Lubomir, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a3sfliiplrn8tmimgca4gutgo7